Skip to content

Rhythmic Breathing Integrated with Hugo Point Acupressure V.S. Vapocoolant Spray on Pain Intensity During Needle Insertion into Arteriovenous Fistula in Hemodialysis Patients

Rhythmic Breathing Integrated with Hugo Point Acupressure V.S. Vapocoolant Spray on Pain Intensity During Needle Insertion into Arteriovenous Fistula in Hemodialysis Patients:A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241103063578N1
Enrollment
120
Registered
2024-11-23
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis. Pain, unspecified

Interventions

Intervention 1: Intervention group: Rhythmic Breathing: Participants will practice deep breathing for 2 minutes before needle insertion, inhaling, holding, and exhaling for 3 seconds each. The exercis

Sponsors

College of Nursing, University of Baghdad
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The participants must be male individuals who are receiving regular hemodialysis treatment Alertness The individuals participating in this study are required to be a minimum of 18 years old or older Ability to speak The participants are required to possess an arteriovenous fistula that serves as the access point for dialysis. Participants who do not take analgesics Not having diabetes for over 10 years

Exclusion criteria

Exclusion criteria: Patients who are experiencing severe pain or discomfort that is not associated with the needle insertion procedure are to be excluded Patients who have documented allergies or hypersensitivity reactions to vapocoolant spray Patients who have undergone recent surgical procedures or have experienced trauma in proximity to the arteriovenous fistula are disqualified Patients exhibiting cognitive impairment or mental health disorders that may hinder their ability to comprehend instructions or provide informed consent Patients presenting with active infections or complications at the site of the arteriovenous fistula Inflammation or injury at the Hugo point .

Design outcomes

Primary

MeasureTime frame
Primary outcome variable is the level of pain, which can be altered based on the Hugo point acupressure, Rhythmic breathing, and vapocoolant spray. Timepoint: Two minute before needle insertion and during insertion. Method of measurement: Visual analog scale (VAS) will be use to assess intensity of pain.

Countries

Iraq

Contacts

Public ContactHassan Raysan Mohammad

University of Baghdad, College of Nursing

Hasan.band2302m@conursing.uobaghdad.edu.iq+964 1 521 1494

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026